by Sven Loosvelt and Siel Demeyer
Companies that invest in innovation can benefit from several tax incentives. For instance, companies with certain intellectual property rights can take advantage of the innovation deduction. This deduction is calculated based on the income generated from these intellectual property rights.
The innovation deduction applies to income from:
Patents;
Supplementary protection certificates;
Computer programs (software);
Plant breeder’s rights;
Orphan drugs;
Government-granted data or market exclusivity.
In practice, the most common intellectual property rights are patents and computer programs (software). A patent protects a technical invention, which must be new, inventive and industrially applicable.
Interestingly, software that is only used within a company (and therefore not commercialised) also qualifies. Both owners and users (usufructuaries, licensees) can benefit from this measure.
However, trademarks and other marketing-related intellectual property rights, such as trade names or domain names, are excluded from the scope of the innovation deduction.
Thanks to the innovation deduction, a company can deduct 85% of the net innovation income from the taxable base in corporate income tax. The qualifying income includes license fees, royalties, income from the sale of intellectual property rights, and damages received. These incomes must be reduced by the related R&D expenditures of the year in which the income was realized, as well as the historical R&D expenditures related to the intellectual property right. However, historical costs can be spread over a period of up to seven tax years.
The deduction is further limited to the proportion of qualifying R&D expenditures (increased by 30%) in the total R&D expenditures related to the intellectual property right. Qualifying R&D activities are activities that are carried out by the company itself or outsourced to independent third parties, such as external laboratories or universities. Expenditures for R&D activities outsourced to affiliated companies or for the acquisition of intellectual property rights are non-qualifying R&D expenditures.
It is therefore very important that R&D activities and intellectual property rights are properly structured within the group in order to optimise the application of the innovation deduction.
Companies wishing to avail of the innovation deduction must comply with extensive documentation requirements. For each intellectual property right, the company must keep available evidence regarding the actual value of the intellectual property rights acquired, the amount of net and gross innovation income and the calculation of qualifying and global expenditure.
At Vandelanotte, we are ready to help you prepare the necessary documentation for the innovation deduction. Contact your account manager or one of our specialists using the form below.
This form can only be sent with the use of technical cookies. You can accept these cookies here.
These cookies are used to distinguish people from bots. Certain data, such as your IP address or language preference, can be sent to Google. More information in our cookie policy.
Sven Loosvelt
Certified Tax Advisor sven.loosvelt@vdl.be
Siel Demeyer
Senior Advisor Tax siel.demeyer@vdl.be
Disclaimer
In our opinions, we rely on current legislation, interpretations and legal doctrine. This does not prevent the administration from disputing them or from changing existing interpretations.
Read our latest insights and news releases to stay abreast of changes in your industry.